Show summary Hide summary
As interest in off-label and plant-based psychoactive products grows, Dr. Drew Pinsky has publicly warned about increasing use of ketamine and kratom and the health risks that can follow. His alert underscores mounting concerns about safety, inconsistent regulation, and the potential for serious side effects as more people pursue these substances for depression, pain or recreation.
Why the warning matters now
The conversation matters because both substances are more visible than ever: clinics offering ketamine therapy have expanded, and online marketplaces sell kratom widely. That accessibility means ordinary consumers, not only patients under medical supervision, may encounter these drugs — sometimes without clear information on dose, purity or interactions.
Manteno mayor issues apology after tense exchange with middle schoolers cleaning park
Shohei Ohtani slump puts Dodgers’ NLDS fate in doubt vs Braves
Different uses, overlapping risks
Ketamine has a legitimate role in medicine — as an anesthetic and, in controlled clinical settings, as a rapid-acting treatment for some forms of depression. Yet outside supervised programs, recreational or unsupervised use can lead to disorientation, impaired judgment, bladder problems and, in rare cases, life-threatening complications.
Kratom, a botanical product derived from a Southeast Asian tree, is marketed by some as an alternative to opioids or as a mood enhancer. It acts on opioid receptors and can cause dependence, withdrawal symptoms and dangerous interactions with prescription medications, particularly those that affect breathing or serotonin levels.
What health professionals are saying
Clinicians and poison-control specialists increasingly report cases linked to both substances — ranging from adverse reactions to mixed-substance overdoses. Experts emphasize that the lack of standardized dosing for kratom and variations in street ketamine purity increase unpredictability.
- Unpredictable potency: Nonmedical ketamine and kratom products can vary widely in strength and contaminants.
- Drug interactions: Combining these substances with alcohol, benzodiazepines, opioids or antidepressants raises the risk of respiratory depression and other severe effects.
- Dependence and withdrawal: Regular kratom use can result in physical dependence; abrupt cessation may provoke withdrawal symptoms.
- Delayed care: Stigma or self-treatment can delay medical attention when complications arise, worsening outcomes.
Practical advice for readers
If you or someone you know is considering treatment options for depression or chronic pain, talk with a licensed clinician about evidence-based choices and known risks. For those already using these substances, awareness and caution are essential.
Steps to reduce immediate risk include:
- Discuss any planned ketamine therapy with a board-certified provider and confirm clinic accreditation and monitoring practices.
- Avoid mixing kratom or ketamine with alcohol, sedatives or prescription opioids.
- Seek medical attention for symptoms such as severe dizziness, breathing difficulty, chest pain, confusion, or loss of consciousness.
- Be honest with health professionals about substance use to ensure appropriate treatment.
Policy and public-health implications
Dr. Drew’s comments feed into broader debates about how to regulate emerging therapies and plant-based products. Public-health advocates call for clearer labeling, robust safety studies and better clinician education so patients can weigh benefits and harms accurately.
For now, the balance between therapeutic promise and public safety remains unsettled. As availability increases, so does the need for reliable information and medical oversight.
Bottom line: Greater access to ketamine and kratom has expanded both therapeutic options and potential harms. Consumers should proceed with caution, prioritize medical guidance, and seek immediate care for worrying symptoms.
